Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

hypersensitivity/albumiin

Link salvestatakse lõikelauale
9 tulemused

Modified serum albumin with reduced affinity for nickel and copper

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION This invention relates in general to a modified serum albumin useful as a blood volume expander, and in particular to a recombinant or otherwise modified serum albumin that is mutated such as by truncation, elongation or insertion at its n-terminal region which has

Modified serum albumin with reduced affinity for nickel and copper

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION This invention relates in general to a modified serum albumin useful as a blood volume expander, and in particular to a recombinant or otherwise modified serum albumin that is mutated such as by truncation, elongation or insertion at its n-terminal region which has

Serum albumin compositions for use in cleansing or dermatological products for skin or hair

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION This invention relates in general to the use of a serum albumin composition as a cleansing or dermatological agent, and more specifically relates to the use of serum albumin, preferably human serum albumin produced by recombinant means, in shampoos, soaps, creams and oils for

Method for treating allergic dermatitis

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION The present disclosure relates to the treatment of allergic dermatitis, and in particular to allergic dermatitis resulting from contact with naturally-occurring hydrophobic toxins such as urushiol and isosolenopsin A. BACKGROUND OF THE INVENTION Allergic dermatitis can be

Method of treating allergic asthma with antibodies to IL-6

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The sequence listing in the file named "56256o2006.txt" having a size of 332,224 bytes that was created Sep. 26, 2017 is hereby incorporated by reference in its entirety. BACKGROUND OF THE INVENTION Field of the Invention This invention is an extension of Applicants' prior invention disclosed in the

Fusion polypeptides

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD The invention relates to fusion polypeptides. It concerns fusion polypeptides comprising an IgE-binding domain and a human serum albumin (HSA) component and salts thereof. It also concerns polynucleotides and physiologically functional equivalent polypeptides which are intermediates in the

Leukotriene by amides and hydrazides

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
RELATIONSHIP TO THE PRIOR ART The concept of using conjugates of leukotrienes in a radioimmunoassay was described, by L. Levine, R. A. Morgan, R. A. Lewis, K. F. Austin, D. A. Clark, A. Marfat, and E. J. Corey, Proceeding of the National Academy of Sciences, U.S.A., Vol. 78, No. 12 7692 (1981) This

Conjugates of leukotrienes with proteins

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
RELATIONSHIP TO THE PRIOR ART The concept of using conjugates of leukotrienes in a radioimmunoassay was described, by L. Levine, R. A. Morgan, R. A. Lewis, K. F. Austin, D. A. Clark, A. Marfat, and E. J. Corey, Proceeding of the National Academy of Sciences, U.S.A., Vol. 78, No. 12 7692 (1981). This

Water soluble extract from nonpathogenic aerobic corynebacteria

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a novel water soluble extract from nonpathogenic aerobic corynebacteria. More particularly, the invention relates to a water soluble extract from nonpathogenic aerobic bacteria, the said extract having the following
Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge